Back to results
US 2011/0236929 A1Published application
E. coli bl21 strain lacking a functional group ii capsular gene cluster
AssigneeNovo Nordisk A/S
InventorsHelle Fabricius Wöldike, Jianhui Deng, Xin Zhao, Yun Liu, Jing Su
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel non-pathogenic Escherichia coli (E. coli) B BL21 strain comprising a deletion of group II capsular gene cluster, and the use thereof for the production of peptides.
Claims15
An E. coli B BL21 strain characterised by having an irreversibly inactivated group II capsular gene cluster.
Dependencies are inferred from the claim text.